Guangdong Jiaying Pharmaceutical Co., Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 402.77 million compared to CNY 355.5 million a year ago. Revenue was CNY 402.77 million compared to CNY 355.5 million a year ago. Net income was CNY 4.49 million compared to net loss of CNY 0.253203 million a year ago. Basic earnings per share from continuing operations was CNY 0.0089 compared to basic loss per share from continuing operations of CNY 0.0005 a year ago. Diluted earnings per share from continuing operations was CNY 0.0089 compared to diluted loss per share from continuing operations of CNY 0.0005 a year ago.